• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Youth, Antidepressant Medications, and Type 2 Diabetes

Youth, Antidepressant Medications, and Type 2 Diabetes

May 1, 2018
Adam Strassberg, MD.
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Adam Strassberg, MD. Dr. Strassberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Review of: Burco M et al, JAMA Pediatrics 2017;171(12):1200–1207

Over the last decade, several published studies have reported an increased risk of type 2 diabetes associated with antidepressant use in adults. But does the same hold true for children and adolescents?

This paper is the first population-based study to examine the risk of onset of type 2 diabetes with the use of antidepressants in younger patients.

Medicaid administrative claims data from California, Florida, Illinois, and New Jersey were analyzed in a cohort of 119,608 youths, ages 5–20, who initiated treatment with antidepressants from 2005 through 2009. Regression models were used to analyze the risk of onset of type 2 diabetes relative to antidepressant use, duration, and dosing.

Current use of antidepressants was associated with a 1.92 adjusted relative risk for type 2 diabetes (95% CI, 1.43–2.57). Current users of SSRIs or SNRIs had a 1.88 adjusted relative risk (95% CI 1.34–2.64), and current users of TCAs had a 2.15 adjusted relative risk (95% CI 1.06–4.36). There were no elevated risks in current users of antidepressants other than SSRIs, SNRIs, or TCAs.

For SSRIs or SNRIs, the risk of onset of type 2 diabetes increased with longer durations of exposure and with larger cumulative dosing. Compared to risk for their use for the first 90 days, there was a relative risk of 1.68 (CI 0.83–3.40) for 91–150 days of use, 2.56 (CI 1.29–5.08) for 151–210 days of use, and 2.66 (CI 1.45–4.88) for > 210 days of use.

Compared to risk after a cumulative antidepressant dose of 1 mg–1500 mg of fluoxetine hydrochloride equivalents, there is a relative risk of 1.22 (CI 0.59–2.52) for 1501 mg–3000 mg of dose equivalents, 2.17 (1.07–4.40) for 3001–4500 mg of dose equivalents, and 2.44 (1.35–4.43) for > 4500 mg of dose equivalents.

CCPR’s Take
The study suggests that long-term antidepressant use, particularly with SSRIs or SNRIs, is associated with increased risk of onset of type 2 diabetes mellitus in children and adolescents. This increased risk is particularly prominent with long-term use and higher daily doses. But the study is observational and must be interpreted with caution. Causality cannot be inferred; however, there is a correlation. Type 2 diabetes mellitus represents a rare but serious adverse outcome to discuss with patients and families, and we should vigilantly monitor for it.
Child Psychiatry
KEYWORDS antidepressants child-psychiatry psychopharmacology_tips
Adam Strassberg, MD.

Can Mindfulness-Based Stress Reduction Affect Symptom Outcomes in Older Adults?

More from this author
www.thecarlatreport.com
Issue Date: May 1, 2018
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Psychotropic Risks in Children and Adolescents, CCPR, May/June 2018
Informed Consent: An Ongoing Process for Focused Care
Embracing Conflict in the Consent Process
Considerations When Prescribing Psychotropic Medications
Metformin to Control Antipsychotic-Induced Weight Gain in Children
Tips for Good Medication Practice
Youth, Antidepressant Medications, and Type 2 Diabetes
DOWNLOAD NOW
Featured Book
  • CMFB2e_Cover.png

    (PRE-ORDER) Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

    All the important facts covering child and adolescent psychopharmacology.
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto52138604.jpg
    Child Psychiatry

    Readily Available and Easily Abused Over-the-Counter Medications

    Reviewing four commonly abused substances that are legally available for purchase: Dextromethorphan, antihistamines, pseudoephedrine, and Kratom.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.